Molecular Templates Inc Bolsa (OTC: MTEM)

Últimas noticias sobre Molecular Templates Inc (OTC:MTEM) Bolsa

Molecular Templates

AADI

APTO

CADL

CARA

HUMA

MESO

MOBX

MTEM

NVNI

OCEA

PRFX

QUBT

ZCAR

FedEx sube un 8,7% con resultados sólidos y una nueva estrategia. Descubre otras acciones destacadas en premercado hoy.

Las acciones de FedEx (FDX) suben alrededor de un 9%; 20 acciones que se mueven en premercado

Molecular Templates Inc

MOLECULAR TEMPLATES INC by Molecular Templates, Inc.

The typical compensation package for S&amp;P 500 CEOs rose by nearly 10% in 2024, according to an Associated Press <a href="https://apnews.com/article/ceo-pay-compensation-pay-ratio-perks-1b968327984edfc67486c2e0e3dc2fff">CEO compensation survey</a>.&nbsp;
The median pay package for CEOs rose to $17.1 million in 2024, up 9.7% from the previous year. Meanwhile, median compensation for employees at these companies went up just 1.7% to $85,419.
Additionally, the S&amp;P 500 rose 23% in 2024, and profits for those companies went up 9%.&nbsp;
"2024 was expected to be a strong year, so the (nearly) 10% increases are commensurate with the timing of the pay decisions," Dan Laddin, a partner at Compensation Advisory Partners, told AP.
Don't Miss:
<ul class="wp-block-list">
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – Many are rushing to <a href="https://www.benzinga.com/money/mode-mobile-2">grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
Raises for the average employee were "long overdue," according to Institute for Policy Studies Global Economy Project Director Sarah Anderson. Still, many workers in the U.S. struggle to pay their bills, especially lower earners.&nbsp;
Top earners in the survey included Axon Enterprises&#8217; (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXON#NASDAQ">AXON</a>) Rick Smith, who has a pay package valued at $164.5 million, GE Aerospace's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) Lawrence Culp, Apple's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPL#NASDAQ">APPL</a>) Tim Cook, Carrier Global's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CARR#NYSE">CARR</a>) David Gitlin, and Netflix's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) Ted Sarandos.&nbsp;
The bulk of the pay packages for these top earners consisted of stock or options awards, the survey found. The median stock award went up by 15% in 2024, while base salaries only grew by 4%.
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
"For CEOs, target long-term incentives consistently increase more each year than salaries or bonuses," Melissa Burek, a partner with Compensation Advisory Partners, told the AP. "Given the significant role that long-term incentives play in executive pay, this trend makes sense."
Morningstar Sustainalytic Senior Director of Stewardship Jackie Cook also told the AP that there are benefits to tying CEO pay to performance, but noted that increased use of share-based pay has led to a "phenomenal rise" in CEO compensation "tracking recent years' market performance," which has "widened the pay gap within workplaces."
At half the companies included in the survey, it would take the average worker 192 years to make what their CEOs make in one year, according to the AP. This pay ratio tends to be highest in industries where wages are low, like fast food or hospitality.
"With CEO pay continuing to climb, we still have an enormous problem with excessive pay gaps," Anderson told the AP. "These huge disparities are not only unfair to lower-level workers who are making significant contributions to company value – they also undercut enterprise effectiveness by lowering employee morale and boosting turnover rates."
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
</ul>
Image: Shutterstock

Personal Finance

APPL

AXON

CARR

NFLX

Median CEO Pay Topped $17.1 Million In 2024, While Median Employee Pay Increased Just 1.7%

VEON Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEON#NASDAQ">VEON</a>), a global digital operator ("VEON" or the "Company"), today announces that Kyivstar, its digital operator in Ukraine, has received regulatory approval to conduct testing of Starlink Direct-to-Cell (D2C) services from the Ukrainian National Commission for the State Regulation of Electronic Communications, Radio Frequency Spectrum and the Provision of Postal Services (NCEC). Today's regulatory approval for field testing follows successful integration of Kyivstar's core mobile network with Starlink's Direct-to-Cell service.
The planned launch of D2C services with support for SMS and over-the-top (OTT) messaging is scheduled for Q4 2025 and is expected to further enhance Kyivstar's ability to provide essential connectivity for Ukraine, especially in areas impacted by infrastructure damage and rural regions, as well as during emergencies. Field testing is planned to commence in select Ukrainian regions this summer, beginning with text message services.

News

VEON

VEON's Kyivstar Receives Regulatory Approval To Conduct Testing Of Starlink D2C Services From Ukrainian NCEC

EQT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQT#NYSE">EQT</a>) has outperformed the market over the past 15 years by 12.91% on an annualized basis producing an average annual return of 25.07%. Currently, EQT has a market capitalization of $35.34 billion. 
Buying $100 In EQT: If an investor had bought $100 of EQT stock 15 years ago, it would be worth $2,831.89 today based on a price of $59.04 for EQT at the time of writing.
<h3>EQT's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750261512_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today

McDonald's Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) just launched a new burger in the UK called The Big Arch, but the only thing getting grilled this week <a href="https://www.benzinga.com/quote/MCD/news">is the stock</a>.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0618"><img loading="lazy" decoding="async" width="628" height="486" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/18111101/Screenshot-2025-06-18-at-3.49.13-PM.png" alt="" class="wp-image-954087" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/18111101/Screenshot-2025-06-18-at-3.49.13-PM.png 628w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/18111101/Screenshot-2025-06-18-at-3.49.13-PM-300x232.png 300w" sizes="(max-width: 628px) 100vw, 628px" /></a></figure>
<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0618">Chart created using Benzinga Pro</a>
McDonald's is now trading below its 200-day simple moving average (SMA) — a widely watched indicator — in what looks like a full technical breakdown. For the Golden Arches, that's not exactly a golden signal.
Shares of the fast-food giant have been sliding underperforming the S&amp;P 500. Over the past month, MCD has lost 9%, and it's now down slightly for the year. The trend is unmistakably bearish: the stock is trading below its eight-day, 20-day, and 50-day exponential moving averages — a technical trifecta that often spells continued downside.
McDonald's Relative Strength Index (RSI), which measures whether a stock is overbought or oversold, has fallen to 25.75. That's well below the 30-level often considered oversold territory — but low RSI alone doesn't guarantee a bounce.
Read Also: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45888833/mcdonalds-just-got-hammered-by-weight-loss-drugs-twice">McDonald&#8217;s Just Got Hammered By Weight-Loss Drugs — Twice</a>
Meanwhile, the Moving Average Convergence Divergence (MACD), which tracks momentum, is flashing a negative 4.84. This suggests the bears still have control and that further pressure may lie ahead.
That view is echoed in the options market, where traders appear to be <a href="https://moneymorning.com/2025/06/17/options-traders-hit-the-drive-thru-on-mcdonalds-mcd-stock/">positioning</a> against a near-term rebound. Total options volume surged over 71% above the monthly average, with a heavy skew toward calls — but sentiment was actually negative. How? Most of the call activity reflected credit strategies, where traders bet that MCD won't rise beyond key levels, effectively collecting premiums from bullish speculators.
And yet, McDonald's is doing what it can to stir up appetite — literally. "The Big Arch" burger just <a href="https://www.thedrum.com/news/2025/06/18/why-leo-burnett-turned-tiktok-launch-mcdonald-s-the-big-arch">dropped</a> in the UK and Ireland, with plans to become a permanent fixture on the menu. 
But for U.S. investors, the real question is whether the sizzle of new products can offset the chill in its chart. Until the stock reclaims key levels &#8211; especially the 200-day SMA — the setup remains firmly bearish.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45931482/starbucks-at-a-crossroads-analyst-sees-chipotle-like-potential-but-warns-of-declining-value-perception">Starbucks At A Crossroads, Analyst Sees Chipotle-Like Potential But Warns Of Declining Value Perception</a></li>
</ul>
Image: Shutterstock

Technicals

McDonald's Stock Slips Below 200-Day Line — Can 'The Big Arch' Reverse The Slide?

Legal

'EU Antitrust Regulators To Open Full-Scale Investigation Into $36B Mars Bid For Kellanova; Regulators Concerned About Mars' High Market Share In Some Products In Some Eu Countries; Mars Unlikely To Offer Remedies During EU Regulators' Preliminary Review Of Deal, Sources Say' - Reuters Exclusive

Marvell Technology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) shares are surging Wednesday after multiple analysts reiterated positive ratings following the company&#8217;s <a href="https://www.benzinga.com/quote/MRVL/analyst-ratings">custom AI investor event</a>.
What Happened: Marvell showcased its comprehensive technology platform that aims to enable the next generation of custom AI infrastructure at an <a href="https://www.marvell.com/content/dam/marvell/en/company/assets/marvell-custom-ai-investor-event-2025.pdf">event</a> on Tuesday. 
Following the presentation, several analysts reiterated Buy ratings. Here&#8217;s a look at the analyst updates that rolled in on Wednesday:
<ul class="wp-block-list">
<li>BofA Securities analyst Vivek Arya maintained Marvell with a <a href="https://www.benzinga.com/analyst-stock-ratings">Buy</a> and raised the price target from&nbsp;$80&nbsp;to&nbsp;$90.</li>
</ul>
<ul class="wp-block-list">
<li>Rosenblatt analyst Kevin Cassidy maintained Marvell with a Buy and a price target of&nbsp;$124.</li>
</ul>
<ul class="wp-block-list">
<li>Benchmark analyst Cody Acree reiterated Marvell with a Buy rating and maintained a price target of&nbsp;$95.</li>
</ul>
<ul class="wp-block-list">
<li>Needham analyst Quinn Bolton reiterated Marvell with a Buy and maintained a price target of&nbsp;$85.</li>
</ul>
Marvell highlighted an expanded opportunity with custom XPU attach and said it sees a 26% increased in its data center total addressable market over the coming years. The company now forecasts a data center TAM of $94 billion, up from $75 billion previously. 
Marvell on Wednesday also announced a <a href="https://www.benzinga.com/pressreleases/25/06/g45994385/empower-and-marvell-announce-collaboration-on-next-generation-integrated-power-delivery-solution-f">collaboration</a> with Empower Semiconductor in which Empower will develop optimized integrated power solutions for Marvell&nbsp;custom silicon platforms. The companies aim to support the increasing demands of next-generation XPUs.
MRVL Price Action: <a href="http://benzinga.com/quote/MRVL">Marvell Technology shares</a> were up 6.94% at $74.85 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/45978623/marvell-launches-new-power-regulator-and-2nm-memory-chips-to-boost-ai-cloud-efficiency">Marvell Launches New Power Regulator And 2nm Memory Chips To Boost AI, Cloud Efficiency</a></li>
</ul>
Photo: JHVEPhoto/Shutterstock.

Price Target

Reiteration

Movers

MRVL

Marvell Technology Stock Is Soaring Wednesday: What's Going On?

<a href="https://www.coinbase.com/en-ca/blog/coinbase-derivatives-and-nodal-clear-partner-in-usdc-integration" title="https://www.coinbase.com/en-ca/blog/coinbase-derivatives-and-nodal-clear-partner-in-usdc-integration">https://www.coinbase.com/en-ca/blog/coinbase-derivatives-and-nodal-clear-partner-in-usdc-integration</a>

COIN

CRCL

'Coinbase Derivatives And Nodal Clear Partner In USDC Integration'

WIIM

MAIA

MAIA Biotechnology shares are trading higher after the company announced a master clinical supply agreement with Roche for hand-to-treat cancer therapies.

Aptevo Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APVO#NASDAQ">APVO</a>) stock is surging on Wednesday.
As per <a href="https://www.benzinga.com/pro/feature/newsfeed" target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>, the stock is trading higher with a strong volume of 81.8 million compared to the average volume of 275.3k.
What Happened: Aptevo revealed new clinical data from its ongoing Phase 1b/2 RAINIER trial evaluating mipletamig, its first-in-class CD123 x CD3 bispecific antibody, in combination with standard-of-care venetoclax and azacitidine (ven/aza) for newly diagnosed patients with acute myeloid leukemia (AML) who are unfit <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">for intensive chemotherapy</a>.
Across two trials, the mipletamig triplet therapy delivered remissions in 85% of evaluable frontline AML patients, significantly exceeding results from competitor studies, including those achieved in the Viale A trial that evaluated venetoclax and azacitidine (ven/aza) <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/ac45992952/mipletamig-demonstrates-compelling-clinical-activity-in-frontline-aml" rel="noreferrer noopener">as doublet therapy</a>.
One patient who was taken off study and successfully received a transplant.
Also Read: <a href="https://www.benzinga.com/25/03/44423176/aptevo-therapeutics-says-two-additional-patients-in-early-stage-leukemia-trial-achieve-remission-within-30-days-of-treatment" target="_blank" rel="noreferrer noopener">Aptevo Therapeutics Says Two Additional Patients In Early-Stage Leukemia Trial Achieve Remission Within 30 Days of Treatment</a>
One CR patient had no minimal residual disease (MRD-negative status) but did have the genetic biomarker TP53, which is associated with resistance to chemotherapy and some targeted therapeutics.
These updated results from the RAINIER dose expansion trial demonstrate a compelling efficacy advantage alongside a strong safety profile.
No cytokine release syndrome (CRS) was observed in either cohorts 1 or 2.
Cohort 3 Nears Full Enrollment at highest dose level evaluated to date in combination therapy.
Why It Matters: AML remains an aggressive and difficult-to-treat blood cancer, particularly for older or medically unfit patients, where treatment options are limited and outcomes are generally poor.
To date, results from the RAINIER trial demonstrate mipletamig&#8217;s increasingly impressive clinical profile, highlighting its potential as a differentiated, highly targeted immunotherapy with a compelling safety profile.
Additionally, on Wednesday, Aptevo Therapeutics announced a registered direct <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/ac45998311/aptevo-therapeutics-announces-8-million-offering-priced-at-the-market-under-nasdaq-rules" rel="noreferrer noopener">offering of $8 million</a>.
The company offered 2.465 million shares or pre-funded warrants to purchase up to 12.325 million at $3.25 per share and associated warrants.
The warrants will have an exercise price of $3.25 per share.
Price Action: APVO stock is up 137.2% at $6.69 at the last check on Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/biotech/25/04/44772476/omeros-advances-high-potential-leukemia-drug-development-stock-moves-higher" target="_blank" rel="noreferrer noopener">Omeros&#8217; New Leukemia Drug Team Ignites Hope For Cancer Fight</a></li>
</ul>

Biotech

Health Care

General

APVO

Aptevo Therapeutics Touts Data From Investigational Drug Trial For Aggressive Blood Cancer

Rumors

IPOs

SLDE

Slide Insurance IPO Quoting $21.05/Share On 1.355M Shares; IPO Priced At $17/Share On 24M Shares

Caris Life Sciences IPO Indicating $28.50/Share On 902K Shares

Shares of Marvell Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) rallied in early trading on Wednesday, after the company hosted its <a href="https://www.benzinga.com/topic/artificial-intelligence">Custom AI Investor Event</a> on Tuesday.
<ul class="wp-block-list">
<li>Needham <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5e21cde3430dee0001c717dd/quinn-bolton">analyst Quinn Bolton</a> maintained a Buy rating and price target of $85.</li>
<li>JPMorgan <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/59f1c1bdefacff0001706787/harlan-sur">analyst Harlan Sur</a> reiterated an Overweight rating and price target of $130.</li>
</ul>
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Needham: Marvell indicated that it estimates its Data Center TAM (total addressable market) at $94 billion in 2028. That&#8217;s up from its previous projection of $75 billion. All four subsegments of the division are expected to contribute to this growth, Bolton said in a note.
Marvell introduced ‘Custom XPU attach', which represents "an increasingly strategic portion of its Data Center TAM," growing at a CAGR (compounded annual growth rate) of 90% from 2023-2028, "significantly outpacing the 47% CAGR of the Custom XPU segment. "We see Custom XPU attach as a particularly rich opportunity for MRVL given its networking and processing background," he further wrote.
JPMorgan: Marvell presented a "compelling and sustainable growth strategy for its AI datacenter networking/ASIC business," Sur said. With new design wins confirmed, the company now has design wins for 18 multi-generational sockets, "which should help drive its ASIC AI silicon market share to 20% by 2028," he added.
"The team is driving strong product innovation and investing in sustaining its leading-edge technology, given its strong R&amp;D scale ($2B+ per year)," the analyst wrote. If Marvell executes well on its datacenter growth strategy and captures 20% of the datacenter TAM opportunity by 2028, there could be "significant upside' to its stock, he further stated.
Price Action: Shares of Marvell Technology had risen by 8.36% to $75.84 at the time of publication on Wednesday.
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/45978623/marvell-launches-new-power-regulator-and-2nm-memory-chips-to-boost-ai-cloud-efficiency">Marvell Launches New Power Regulator And 2nm Memory Chips To Boost AI, Cloud Efficiency</a></li>
</ul>
Image: Shutterstock

Analyst Color

Analyst Ratings

Marvell Technology Has 'Sustainable Growth Strategy,' Analysts Say

IMNN

IMUNON shares are trading lower. The company announced the presentation of new positive translational data from the Phase 2 OVATION 2 Study of IMNN-001.

The European Central Bank (ECB) announced that demand for Euro-denominated international bonds and loans increased 40% in 2024, reaching levels not seen since the global financial crisis.
Euro-denominated bonds issued by US firms, known as "Reverse Yankees," surged to nearly $95 billion last year, compared to $60 billion in 2023, the ECB said in a <a target="_blank" rel="noreferrer noopener" href="https://www.ecb.europa.eu/press/other-publications/ire/html/index.en.html">recent report</a>. Firms seeking cheaper capital, driven by a growing interest rate disparity across the Atlantic, fueled the increase.
"There is evidence of a link between shifts in invoicing currency patterns in global trade and geopolitical alignments," ECB President Christine Lagarde said in the opening remarks of the report published on June 11. "New challenges to the euro's international role have also emerged, including initiatives promoting the global use of cryptocurrencies."
<figure class="wp-block-image"><a href="https://substackcdn.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F25d8fa66-4a00-4316-ace1-277f6e3f4f55_920x495.png" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://substackcdn.com/image/fetch/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F25d8fa66-4a00-4316-ace1-277f6e3f4f55_920x495.png" alt="" /></a><figcaption class="wp-element-caption">The latest snapshot of the international monetary system, Source: BIS, IMF, CLS Bank</figcaption></figure>
Despite this resilience in international finance, the euro has lost its longstanding position as the second-largest foreign reserve asset.<a href="https://www.benzinga.com/markets/commodities/25/06/45900930/gold-surpasses-euro-to-become-second-largest-reserve-asset-still-far-behind-dollar-ecb-says" target="_blank" rel="noreferrer noopener"> Gold</a>, which surged in both price and official holdings in 2024, has replaced it. 
Central banks purchased more than 1,000 tons of gold, double the decade average, driving their share of global reserves to 20%, compared to the euro's 16%.
Gold's strong demand over the last three years reflects the growing global mistrust of fiat currencies. Ongoing geopolitical tensions have increased the risks of fiscal deficits and monetary debasement, given the plans such as Readiness 2030, which sees <a target="_blank" rel="noreferrer noopener" href="https://commission.europa.eu/topics/defence/future-european-defence_en">€800 billion in defense spending</a>.
<h2 class="wp-block-heading">ECB Policy Focuses on Cutting Rates, Growth</h2>
In response to Eurozone inflation at <a target="_blank" rel="noreferrer noopener" href="https://ec.europa.eu/eurostat/web/products-euro-indicators/w/2-18062025-ap">just 1.9%</a>, the ECB has halved its benchmark rate over the past year, with its policy rate now standing at 2%. Services inflation has cooled from 4% to 3.2%, while goods inflation remains subdued at 0.6%.
"In our mission we have price stability but we also know that there cannot be price stability without financial stability," Lagarde said in a <a target="_blank" rel="noreferrer noopener" href="https://www.youtube.com/watch?v=JgdgTa7P4Yk">recent interview</a> for CGTN. "So, we are very focused on monitoring the potential risks, the uncertainty that abounds around the European economy, to anticipate any further consequences and be able to respond. But at this point in time, we have stabilized prices at the level that we were expecting."
Still, with economic growth expectations downgraded and inflation projected to dip further in 2026, the ECB faces the risk of deflationary pressures re-emerging, an echo of the post-2010 euro crisis period.
Further appreciation of the euro could threaten exports and further reduce inflation, potentially prompting additional rate cuts. Meanwhile, the ECB has continued to push for deeper capital market integration and the rollout of a digital euro to bolster the currency's global standing.
<h2 class="wp-block-heading">Swiss Franc's Safe Haven Strength Raises Policy Dilemma</h2>
The Swiss franc is once again proving to be Europe's haven. As geopolitical risks surge, particularly with the latest conflict between Israel and Iran, the franc's attractiveness has continued to grow. Yet, strengthening the currency comes with challenges.
In May, Switzerland returned to deflation for the first time since 2021, with consumer prices falling 0.1% year-over-year. Declines were widespread, from transport to household goods, pushing inflation back to the lower edge, or below, of the Swiss National Bank's (SNB) 0–2% stability target.
<figure class="wp-block-image"><a href="https://substackcdn.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F7cf012a2-b09c-4f3c-a84c-be1b6f5e4aaa_1329x684.png" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://substackcdn.com/image/fetch/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F7cf012a2-b09c-4f3c-a84c-be1b6f5e4aaa_1329x684.png" alt="" /></a><figcaption class="wp-element-caption">Swiss franc against the euro, pound, yen and the US dollar, year-to-date, Source: TradingView</figcaption></figure>
With the franc appreciating, the SNB is under pressure to act. Its next monetary policy meeting on June 19 is expected to deliver another 25 basis point cut, taking the policy rate to zero.
By September, the rate could fall to -0.25% or even -0.75%, reintroducing the controversial era of <a target="_blank" rel="noreferrer noopener" href="https://www.euronews.com/business/2025/06/11/swiss-deflation-fuels-talks-of-negative-interest-rates-is-snb-ready">negative interest rates</a>. The SNB employed negative rates from 2015 to 2022.
Meanwhile, short-dated Swiss government bonds have entered the territory of negative yields. The two-year yield touched as low as -0.225% on June 3, and nearly a quarter of the outstanding Swiss government debt yields less than zero.
That development shows that the strength of the Swiss franc isn't a speculative play, but rather a movement by institutional tactical asset allocators who must manage large cash portfolios.
<h2 class="wp-block-heading">British Pound Is At A Crossroads</h2>
The British pound has seen mixed fortunes in 2025. Once bolstered by high yields and demand for carry trades, sterling fell 1.7% on June 17 to $1.3427—its worst single-day performance in over a month.
The pound's slide followed a string of weak labor market data, including the <a target="_blank" rel="noreferrer noopener" href="https://www.bloomberg.com/news/articles/2025-06-10/uk-employment-drops-most-since-2020-and-wage-growth-cools">sharpest drop in employment</a> in five years and slower-than-expected wage growth, according to data for May.
"The dovish repricing of BOE rate-cut expectations takes some of the shine off the pound," Lee Hardman, a senior currency analyst at MUFG, <a target="_blank" rel="noreferrer noopener" href="https://www.bloomberg.com/news/articles/2025-06-10/weak-uk-jobs-data-sends-down-pound-and-boosts-boe-rate-cut-bets">told</a> Bloomberg. He noted that the strengthening trend is "unlikely on its own to reverse the recent upward trend unless the BOE signals it is more willing to speed up rate cuts."
Bank of England interest rate plot (2016-Present), Source: Bank of England
The Bank of England (BOE), which has already cut rates four times to 4.25%, is facing mounting pressure to ease them further. Markets are fully pricing another rate cut in September and see a 90% chance of an additional move by December.
<h2 class="wp-block-heading">BOE's Rate Journey Remains Unclear</h2>
Yet the path ahead is far from clear. Inflation remains sticky, with April's annual CPI at 3.4%, well above the BOE's 2% target, and expected to rise to 3.7% before cooling in 2026. Thus, opinions diverge on the most optimal policy path.
Some, like BOE committee member Alan Taylor, want <a target="_blank" rel="noreferrer noopener" href="https://www.ft.com/content/e842038f-e4df-4e99-a5be-8b6f12312a12">deeper and faster cuts</a> amid deteriorating growth. Others, including economists at JP Morgan and Schroders, argue that inflationary risks from elevated wage and services costs warrant a more cautious approach.
Options markets reflect this uncertainty, with no apparent bias in the direction.
Nevertheless, the pound remains one of the highest-yielding G10 currencies and has benefited from a rebound in risk appetite. Unless the BOE signals a more aggressive pivot toward easing, or the inflation picture improves substantially, the pound may struggle to maintain its upward momentum.
Disclaimer:
Any opinions expressed in this article are not to be considered investment advice and are solely those of the authors. European Capital Insights is not responsible for any financial decisions made based on the contents of this article. Readers may use this article for information and educational purposes only.&nbsp;
This article is from an unpaid external contributor. It does not represent Benzinga&#8217;s reporting and has not been edited for content or accuracy.

Eurozone

Forex

Econ #s

Opinion

ECB Reports 40% Rise In Euro-Denominated Bonds, Loan Demand

Wall Street&#8217;s aversion to the dollar has reached its highest in two decades. Bank of America&#8217;s June Global Fund Managers Survey indicates that 37% of investors are underweight on the U.S. dollar, the most bearish skew in two years. But this unusual unanimity is flashing something interesting for ETF investors: a contrarian opportunity.
Enter <a href="https://www.benzinga.com/etfs">dollar-bullish ETFs</a>, namely, the Invesco DB US Dollar Index Bullish Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>), WisdomTree Bloomberg U.S. Dollar Bullish Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USDU#NYSE">USDU</a>), and a family of currency-hedged equity ETFs such as iShares Currency Hedged MSCI EAFE (BATS:<a class="ticker" href="https://www.benzinga.com/stock/HEFA#BATS">HEFA</a>) and WisdomTree Japan Hedged Equity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DXJ#NYSE">DXJ</a>).
These are not merely tactical dollar-strength plays; they might also be the wiser alternative to betting on other world currencies in an era of policy pivots, trade shocks, and geopolitical hairpin turns.
Also Read: <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/06/45983526/trump-wants-an-end-not-a-ceasefire-for-the-israel-iran-war-what-that-means-for-etfs">Trump Wants &#8216;An End, Not a Ceasefire&#8217; For The Israel-Iran War: What That Means For ETFs</a>
<h2 class="wp-block-heading">Why Betting Against The Dollar Might Backfire</h2>
The U.S. Dollar Index, which UUP follows, has dropped around 12% since Donald Trump&#8216;s inauguration on Jan 20. Investors struggle with growing deficits, bewildering tariff messages, and a Fed that seems cornered. On paper, that seems like a good enough setup for wagering on other currencies.
But that is not really the case.
The issue? The alternatives are not exactly poster children for stability.
The eurozone is stuck with anemic growth, recalcitrant inflation, and political weakness from Brussels to Berlin.
The Japanese yen is anchored to ultra-loose monetary policy and a hawkish Fed–BoJ divergence.
The Chinese yuan continues to be politically managed and vulnerable to a shaky property market.
Emerging market currencies? Illiquid, volatile, and sharply responsive to risk-off shocks.
Short version: Sure, sentiment might be bearish on the dollar, but there&#8217;s no neat &#8220;long&#8221; substitute. And in FX, betting on currencies other than the dollar can rapidly go off the rails when global risk rises.
<h2 class="wp-block-heading">UUP, USDU: Tactical Bets With Past Tailwinds</h2>
Invesco&#8217;s UUP and WisdomTree&#8217;s USDU offer liquid, directional exposure to a dollar recovery.
UUP tracks the dollar against a basket of six developed-market currencies, with the euro weighing heavily in the mix.
USDU is a broader one, with a mix of emerging markets and more diversified FX. It is a more diversified bet, but dollar-positive nonetheless.
Both the funds are off this year, tracking the decline of the dollar, and that&#8217;s precisely what could make them attractive. In 2005, when sentiment had been equally bearish, the dollar rallied 14% over several months. That rebound caught a vast majority of short-dollar positions by surprise, and paid off for ETF investors who entered early.
<h2 class="wp-block-heading">For The Cautious: Hedge Your International Equity Exposure</h2>
If jumping headfirst into long-dollar ETFs seems reckless, investors can still be defensive through currency-hedged international ETFs such as HEFA (Europe, Australasia, Far East equities, currency-hedged), DXJ (Japan equities, JPY-hedged), and WisdomTree Europe Hedged Equity Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HEDJ#NYSE">HEDJ</a>) (Eurozone exporters, euro-hedged).
These funds allow investors to hold international diversification without being clobbered if the dollar does rally.
<h2 class="wp-block-heading">Positioning Against The Herd</h2>
When most investors are scrambling to discover the next hard currency, the road of least resistance might be to remain humble in the dollar. For it is during a geopolitical environment characterized by tariff brinksmanship, Middle East turmoil, and election-year uncertainty that stability, no matter how flawed, can become a valuable asset.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/specialty-etfs/25/06/45982240/beyond-magnificent-7-can-thematic-etfs-like-ives-lead-the-next-wave-of-ai-investing-cio-cullen-rogers-explains">Beyond Magnificent 7: Can Thematic ETFs Like IVES Lead The Next Wave Of AI Investing? CIO Cullen Rogers Explains</a></li>
</ul>
Photo: Shutterstock

Currency ETFs

ETFs

WisdomTree Trust Japan Total Dividend Fund

HEDJ

HEFA

USDU

PowerShares DB US Dollar Index Bullish Fund

UUP Vs. The Herd: Contrarian Dollar ETFs In Focus As Sentiment Hits 20-Year Low

Zoetis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZTS#NYSE">ZTS</a>) has outperformed the market over the past 10 years by 1.04% on an annualized basis producing an average annual return of 12.01%. Currently, Zoetis has a market capitalization of $69.84 billion. 
Buying $1000 In ZTS: If an investor had bought $1000 of ZTS stock 10 years ago, it would be worth $3,123.56 today based on a price of $156.87 for ZTS at the time of writing.
<h3>Zoetis's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750260611_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Zoetis 10 Years Ago Would Be Worth This Much Today

Amazon.com, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) Amazon&nbsp;Web Services <a target="_blank" href="https://www.benzinga.com/topic/chip" rel="noreferrer noopener">could soon announce</a> an update to its Graviton4 chip, sparking a rivalry with Intel Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) and&nbsp;Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>).
The chip could include 600 gigabits per second of network bandwidth, CNBC <a target="_blank" href="https://www.cnbc.com/2025/06/17/aws-chips-nvidia-ai.html" rel="noreferrer noopener">reported</a> on Wednesday. Benzinga has reached out to Amazon for its comment.
Hyperscalars like Amazon, Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), and Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) migrated&nbsp;towards custom chips to curtail costs, tackle compatibility issues, and address supply crises.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/large-cap/25/05/45702458/amazon-expands-global-data-centers-boosts-access-to-nvidia-ai-chips-for-cloud-customers" rel="noreferrer noopener">Amazon Expands Global Data Centers, Boosts Access To Nvidia AI Chips For Cloud Customers</a>
<h2 class="wp-block-heading">What is the Graviton4 Chip?</h2>
According to Amazon, its latest <a target="_blank" href="https://www.aboutamazon.com/news/aws/graviton4-aws-cloud-computing-chip" rel="noreferrer noopener">cloud computing chip</a>, Graviton4, offers significant advancements in performance and energy efficiency. It&#8217;s the fourth generation of AWS&#8217;s custom-engineered data center chips, first introduced in 2018.
Graviton4, based on Arm-architecture, boasts four times the performance of Graviton1 and is even more energy-efficient than its predecessor, Graviton3. With 73 billion transistors, it&#8217;s being adopted by major customers like SAP and Epic Games for high-performance and reliable cloud experiences. This innovation, alongside other custom AWS chips like Trainium and Inferentia for AI, underscores Amazon&#8217;s leadership in cloud computing technology.
Amazon manufactures Graviton4 central processing unit at its Annapurna Labs in Austin, Texas.
<h2 class="wp-block-heading">Why Does Having A Custom Chip Matter?</h2>
Rami Sinno, director of engineering at Amazon Web Services (AWS) Annapurna Labs, cited strong demand for chips that outpaced the supply.
AWS Senior Director Gadi Hutt told CNBC about Amazon&#8217;s initiatives to provide an alternative to Nvidia Corp&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) costly graphics processing units.
Hutt told CNBC. that Anthropic&#8217;s Claude Opus 4 AI model launched on Trainium2 GPUs and Project Rainier. Trainium3 is coming up in 2025, he said.
AWS has <a target="_blank" href="https://www.benzinga.com/24/12/42309656/amazon-unleashes-powerful-ai-chip-clusters-to-supercharge-anthropics-models-while-challenging-nvidia-and-openais-dominance" rel="noreferrer noopener">committed $8 billion</a> to Anthropic. Also, Amazon chief&nbsp;Andy Jassy <a target="_blank" href="https://www.benzinga.com/markets/tech/25/06/45982631/amazon-ceo-says-generative-ai-will-reduce-total-corporate-workforce" rel="noreferrer noopener">recently highlighted the</a> company&#8217;s extensive leveraging of&nbsp;Generative AI&nbsp;to drive value.
Jassy highlighted Generative AI&#8217;s crucial role within AWS for developers and optimizing internal functions such as fulfillment and customer service. He also pointed to developing AI agents to automate tasks and accelerate innovation.
As Amazon commits huge spending and Capex to AI, it is imperative that it design its own chips based on custom needs rather than relying on NVIDIA.
Jassy stated that this AI-driven transformation might reduce the corporate workforce in the coming years.
Price Action: AMZN stock is up 0.92% at $216.80 at the last check on Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/45978623/marvell-launches-new-power-regulator-and-2nm-memory-chips-to-boost-ai-cloud-efficiency" target="_blank" rel="noreferrer noopener">Marvell Launches New Power Regulator And 2nm Memory Chips To Boost AI, Cloud Efficiency</a></li>
</ul>
Photo by Deep Pixel via Shutterstock

Tech

Media

AMZN

GOOGL

INTC

MSFT

NVDA

Amazon's Powerful AWS Custom Chip To Get An Upgrade - Why Is It Important?

Shares of Circle Internet Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRCL#NYSE">CRCL</a>) are trading higher by 15.5% to $172.29 Wednesday morning. The move higher appears directly linked to the U.S. Senate&#8217;s passage of the GENIUS Act, a bill poised to establish clear regulations for the stablecoin industry.
What To Know: Circle operates as a stablecoin issuer, a business model at the very heart of the new legislation. According to the text of the act, companies in this sector <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45995223/genius-stablecoin-bill-clears-senate-but-trumps-crypto-profits-loom-over-momentum">issue digital tokens</a> that must be backed by highly liquid assets, such as U.S. dollars or short-term Treasury bills. 
The law also mandates that these issuers must publicly disclose the composition of their reserves on a monthly basis, a move intended to bring transparency and stability to the burgeoning market.
Read Also: <a href="https://www.benzinga.com/crypto/25/06/45994132/exclusive-prenetics-acquires-20-million-in-bitcoin-to-boost-healthcare-bitcoin-treasury-strategy">Prenetics Acquires $20 Million In Bitcoin To Boost Healthcare Bitcoin Treasury Strategy</a>
The passage of the GENIUS Act is being hailed as a <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45995223/genius-stablecoin-bill-clears-senate-but-trumps-crypto-profits-loom-over-momentum">watershed moment</a> that provides long-awaited regulatory clarity. Industry leaders project this clarity will unlock trillions in institutional capital, with one expert predicting the stablecoin market could grow to $400 billion by the end of 2025 and $3.5 trillion by 2030. 
This new federal framework is expected to accelerate the adoption of stablecoins for uses like cross-border payments and 24/7 settlements, placing companies like Circle at the forefront of a major financial transformation.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45995593/whats-going-on-with-ast-spacemobile-stock-3">What&#8217;s Going On With AST SpaceMobile Stock?</a>
<h2 class="wp-block-heading">How To Buy CRCL Stock</h2>
By now you're likely curious about how to participate in the market for Circle Internet Group &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Circle Internet Group, which is trading at $172.29 as of publishing time, $100 would buy you 0.58 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
Image: Shutterstock

Circle Internet Group (CRCL) Stock Soars On Landmark Stablecoin Legislation

RBC Capital analyst Christopher Dendrinos downgrades Sunrun (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) from Outperform to Sector Perform and lowers the price target from $12 to $5.

Downgrades

RBC Capital Downgrades Sunrun to Sector Perform, Lowers Price Target to $5

Just hours before the Federal Reserve's June policy meeting, President Donald Trump launched a fresh attack on Fed Chair Jerome Powell while sidestepping direct confirmation of a potential U.S. <a href="https://www.benzinga.com/topic/middle-east">military strike on Iran.</a>
What Happened: Speaking outside the White House on Wednesday, Trump renewed his call for sharply lower interest rates. He argues that the U.S. should be "two to two and a half points lower" given what he described as a low-inflation environment.
"We have almost no inflation. We have only success. I&#8217;d like to see interest rates get down now," Trump said, blaming Powell for the high cost of refinancing U.S. debt. 
He claimed that just a one-point reduction would deliver meaningful relief on refinancing federal debt, while a two-point cut would save even more over long-term maturities.
"We'd be saving $700 billion, $800 billion—trillions over time,&#8221; he says.
Trump describes Powell as someone who "refuses to lower the Fed" and "is not a smart person." Trump went further, accusing Powell of personal bias, saying, "I think he hates me.&#8221;
Read Also:<a href="https://www.benzinga.com/markets/macro-economic-events/25/06/45978856/federal-reserve-rate-cuts-trump-tariffs-what-to-watch-wednesday"> No Rate Cuts Yet, Fed Wants To See Where Tariffs Land: Here&#8217;s What To Watch Wednesday</a> 
<h3 class="wp-block-heading">What About Europe? </h3>
Trump also pointed to Europe's more aggressive monetary easing in 2025.
"Europe had 10 cuts. We had none," he said, adding that some countries with lower rates "can't carry our suitcase."
The remarks come as markets expect the Fed to hold its benchmark rate steady in the 4.25%-4.50% range for the fourth straight meeting, while the updated dot plot may show fewer cuts than traders had previously hoped.
<h3 class="wp-block-heading">Iran Rejects Trump&#8217;s Demands</h3>
When Trump reiterated his demand for an "unconditional surrender," calling Iran "schoolyard bullies" with long-standing hostile intentions, it did nothing to sway Iranian Supreme Leader Ayatollah Ali Khamenei.
According <a href="https://www.reuters.com/world/middle-east/americas/israel-iran-air-war-enters-sixth-day-trump-calls-irans-unconditional-surrender-2025-06-17/">to</a> Reuters, Khamenei rejected Trump&#8217;s demand for &#8220;unconditional surrender&#8221; on Wednesday.
The rejection comes after Trump was pressed on U.S. military intentions following a Situation Room meeting on Tuesday. Trump refused to confirm any immediate plans to strike Iran's nuclear infrastructure.
&#8220;Nobody knows what I&#8217;m going to do,&#8221; Trump said.
Regarding hopes of a new round of negotiations, Trump stated that &#8220;nothing is too late.&#8221;
He added, cryptically, "Next week is going to be very big. Maybe less than a week."
<h3 class="wp-block-heading">Markets Signal De-Escalation For Now</h3>
U.S. markets responded positively to the lack of definitive military escalation. 
The Nasdaq 100 — as tracked by the Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) — rallied by 0.7% to 21,850 at last check Wednesday. The S&amp;P 500 rose 0.6% to 6,025.
The gains came as investors priced in a reduced likelihood of imminent U.S. military action in Iran, and speculated about possible diplomatic openings.
In commodities, gold pulled back, while West Texas Intermediate crude fell to $72 per barrel, down more than 2% from the previous day's high. The U.S. dollar also dipped slightly as global risk sentiment improved.
Read Now:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/economic-data/25/06/45993369/mohamed-el-erian-warns-feds-path-forward-is-clouded-by-trump-tariffs-and-israel-iran-conflict">Mohamed El-Erian Warns Fed&#8217;s Path Forward Is Clouded By Trump Tariffs And Israel-Iran Conflict </a></li>
</ul>
Image: Shutterstock

Government

Regulations

Broad U.S. Equity ETFs

Global

Trump Slams Powell Again, Yet Markets Breathe As Iran Rejects President's Demands

Earnings

Press Releases

Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate Update

Molecular Templates Announces Receipt of Expected Notification of Deficiency from Nasdaq Related to Delayed filing of Quarterly Report on Form 10-Q and Failure to Meet Bid Price Requirements

Markets

Molecular Templates Announces Notice of Delisting and Failure to Satisfy Continued Listing Rules

Management

Calidi Biotherapeutics Announces Chief Executive Officer Transition and Appointment of Eric Poma, Ph.D. as CEO and Director

Calidi Biotherapeutics Reports First Quarter 2025 Financial Results and Recent Operational Highlights

CLDI

Barclays

Comments

Molecular Templates Inc

Noticias

Últimas noticias sobre Molecular Templates Inc (OTC:MTEM) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL